Twin Peaks Medical Imaging Policy & Procedures
HIPAA Health Insurance Portability and Accountability Act (1996)
Purpose: It is the responsibility of TPMI to insure the confidentiality of all patient related information and strictly enforce HIPAA regulations.
Scope: All patient information including but not limited to: patient contact information, patient medical information and patient financial information.
Policy: It is the policy of TPMI to protect all patient information as described by Health Insurance Portability & Accountability Act (April 14, 2003) HIPAA regulations. The HIPPA regulation is posted in the patient waiting area (English and Spanish) and a copy of the regulation will be provided to any patient upon request. Patient medical information will not be released without the written consent of the patient. However medical information may be shared with medical practitioners’ or medical institutions as it is related to our common patients. (Delayed medical information could cause delayed treatment)
Purpose: Address all patient complaints within a reasonable period of time.
Scope: This policy includes all TPMI patients examined by TPMI staff.
Policy: All patient complaints will be directed to the TPMI manager for disposition. All TPMI complaints will be addressed with the patient within a reasonable period of time not to exceed 1 week. If further investigation is necessary that will be explained to the patient upon first contact by the manager.
Concerns will be judged by the manager to pass or not to pass the patient concern up to another level above the manager. i.e. physicians, Board of Directors or COPIC. All concerns at this level will be reported to the Board of Directors.
Administration of Medications
Purpose: This is a guideline as to the administration of medications including but not limited to Contrast, sedatives or controlled agents.
Scope: This policy includes all agents, controlled and not controlled, that may be administered to TPMI patients.
Policy: It is the policy that contrast, including Non-ionic contrast and gadolinium may be administered the technologist of the specific modality requiring the contrast. i.e. MRI-Gadolinium or CT Non-Ionic contrast. A physician must be available upon injection of contrast.
If a patient has a reaction to the contrast the physician must determine the severity of the reaction and decide if 911 should be called.
Under limited circumstances is a technologist to administer sedative drugs or controlled agents. The technologist may, if directed by a physician at the side of the patient in question, inject sedative or controlled drugs into the patient after verifying the drug and amount of the drug with the physician.